AI assistant
XERO LIMITED — Director's Dealing 2016
Aug 4, 2016
66106_rns_2016-08-04_1528f937-6e7d-4a4f-a360-d9ca6d3b916d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
DocuSign Envelope ID: C788B150-A921-454B-A1F0-60B03E37CB03
==> picture [110 x 28] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | Xero Limited(XRO) | |
| Date this disclosure made: | 5 August 2016 | |
| Date of last disclosure: | 14 June 2016 |
| Director or senior managergiving disclosure | ||
|---|---|---|
| Full name(s): | Duncan Ritchie | |
| Name of listed issuer: | Xero Limited(XRO) | |
| Name of related body corporate (if applicable): | Not applicable | |
| Position held in listed issuer: | Chief Platform Officer | |
| Director or senior managergiving disclosure | Director or senior managergiving disclosure | |
|---|---|---|
| Full name(s): | Duncan Ritchie | |
| Name of listed issuer: | Xero Limited(XRO) | |
| Name of related body corporate (if applicable): | Not applicable | |
| Position held in listed issuer: | Chief Platform Officer | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: |
||
| Class of affected quoted financial products: | Ordinary shares in Xero Limited(Ordinary Shares) |
|
| Nature of the affected relevant interest(s): | Beneficial ownership of Ordinary Shares through the Xero Limited Employee Restricted Share Plan (Plan) |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 36,408 | |
| Number held in class after acquisition or disposal: | 42,752 | |
| Current registered holder(s): | Xero Trustee Limited | |
| Registered holder(s)once transfers are registered: | Xero Trustee Limited |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Not applicable | ||
|---|---|---|
| Not applicable | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled or physicallysettled: | Not applicable | |
| Maturitydate of the derivative(if any): | Not applicable | |
| Expirydate of the derivative(if any): | Not applicable | |
| Theprice specified in the terms of the derivative(if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable | |
| For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| 29 July 2016 | ||
| Allocation of Ordinary Shares under the Xero Limited Employee Restricted Share Plan(Plan) |
||
| Not applicable |
DocuSign Envelope ID: C788B150-A921-454B-A1F0-60B03E37CB03
Ordinary Shares allocated, as part of the remuneration package of Duncan Ritchie at a The consideration, expressed in New Zealand dollars, paid or received for the acquisition or value of NZ$18.72 per share disposal. If the consideration was not in cash and cannot be readily by converted into a cash (being the 20 day volume value, describe the consideration: weighted average market price of Ordinary Shares on the NZX Main Board through to 28 July 2016) Number of financial products to which the transaction related: 1 If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: No Whether prior written clearance was provided to allow the acquisition or disposal to proceed Not applicable during the closed period: Date of the prior written clearance (if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
| (a) Ordinary Shares; (b) Options to acquire Ordinary Shares (Options) |
||
|---|---|---|
| (a) Legal ownership of Ordinary Shares; (b) Holder of Options, each Option entitling the holder to subscribe for one Ordinary Share subject to the terms of the Xero Limited Restricted Stock Unit and Option Plan(NZ) |
||
| (a) 42,459; (b) 135,000 | ||
| (a) Duncan Ritchie; (b) Duncan Ritchie |
||
| Not applicable | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | |
| Maturity date of the derivative (if any): | Not applicable | |
| Expiry date of the derivative (if any): | Not applicable | |
| The price's specified terms (if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable | |
| For that derivative relevant interest,- | Not applicable | |
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | |
| Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: |
||
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
| Signature of director or officer: | ||
| Date of signature: | 8/4/2016 |
8/4/2016 | 15:50:19 PDT